148 related articles for article (PubMed ID: 17235644)
1. Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia.
Choi SH; Choo EJ; Kwak YG; Kim MY; Jun JB; Kim MN; Kim NJ; Jeong JY; Kim YS; Woo JH
J Infect Chemother; 2006 Dec; 12(6):380-6. PubMed ID: 17235644
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors, Clinical Presentation, and Outcome of
Ballouz T; Aridi J; Afif C; Irani J; Lakis C; Nasreddine R; Azar E
Front Cell Infect Microbiol; 2017; 7():156. PubMed ID: 28523249
[TBL] [Abstract][Full Text] [Related]
3. Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report.
Garcia Casallas JC; Robayo-Amortegui H; Corredor-Rozo Z; Carrasco-Márquez AM; Escobar-Perez J
J Med Case Rep; 2019 May; 13(1):141. PubMed ID: 31064407
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Mortality in Children with
Choe YJ; Lee HJ; Choi EH
Microb Drug Resist; 2019 Oct; 25(8):1210-1218. PubMed ID: 31120349
[No Abstract] [Full Text] [Related]
5. Risk factors and outcomes for patients with bloodstream infection due to Acinetobacter baumannii-calcoaceticus complex.
Chopra T; Marchaim D; Johnson PC; Awali RA; Doshi H; Chalana I; Davis N; Zhao JJ; Pogue JM; Parmar S; Kaye KS
Antimicrob Agents Chemother; 2014 Aug; 58(8):4630-5. PubMed ID: 24890594
[TBL] [Abstract][Full Text] [Related]
6. The clinical significance of Acinetobacter baumannii in blood cultures.
Seifert H; Baginski R
Zentralbl Bakteriol; 1992 Jul; 277(2):210-8. PubMed ID: 1520980
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Huang ST; Chiang MC; Kuo SC; Lee YT; Chiang TH; Yang SP; Ti-Yin ; Chen TL; Fung CP
J Microbiol Immunol Infect; 2012 Oct; 45(5):356-62. PubMed ID: 22575430
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of invasive Acinetobacter infection: A multicenter investigation with molecular identification of causative organisms.
Kiyasu Y; Hitomi S; Funayama Y; Saito K; Ishikawa H
J Infect Chemother; 2020 May; 26(5):475-482. PubMed ID: 31924521
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Anunnatsiri S; Tonsawan P
Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
[TBL] [Abstract][Full Text] [Related]
10. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.
Seifert H; Strate A; Pulverer G
Medicine (Baltimore); 1995 Nov; 74(6):340-9. PubMed ID: 7500897
[TBL] [Abstract][Full Text] [Related]
11. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
[TBL] [Abstract][Full Text] [Related]
12. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii.
Tseng YC; Wang JT; Wu FL; Chen YC; Chie WC; Chang SC
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):181-90. PubMed ID: 17662564
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
[TBL] [Abstract][Full Text] [Related]
15. Vascular catheter-related bloodstream infection due to Acinetobacter johnsonii (formerly Acinetobacter calcoaceticus var. lwoffi): report of 13 cases.
Seifert H; Strate A; Schulze A; Pulverer G
Clin Infect Dis; 1993 Oct; 17(4):632-6. PubMed ID: 8268343
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
Chusri S; Chongsuvivatwong V; Silpapojakul K; Singkhamanan K; Hortiwakul T; Charernmak B; Doi Y
J Microbiol Immunol Infect; 2019 Oct; 52(5):796-806. PubMed ID: 31031096
[TBL] [Abstract][Full Text] [Related]
17. Case-control analysis of endemic Acinetobacter baumannii bacteremia in the neonatal intensive care unit.
Hsu JF; Chu SM; Lien R; Chiu CH; Chiang MC; Fu RH; Lee CW; Huang HR; Tsai MH
Am J Infect Control; 2014 Jan; 42(1):23-7. PubMed ID: 24176602
[TBL] [Abstract][Full Text] [Related]
18. Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii.
Ku SC; Hsueh PR; Yang PC; Luh KT
Eur J Clin Microbiol Infect Dis; 2000 Jul; 19(7):501-5. PubMed ID: 10968320
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii.
Fu Q; Ye H; Liu S
Am J Infect Control; 2015 Aug; 43(8):857-60. PubMed ID: 25960385
[TBL] [Abstract][Full Text] [Related]
20. Bacteremia due to Acinetobacter species other than Acinetobacter baumannii.
Seifert H; Strate A; Schulze A; Pulverer G
Infection; 1994; 22(6):379-85. PubMed ID: 7698833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
